Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent
US5288704A · kind A · utility
25Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 1992 |
| Grant date | Feb 22, 1994 |
| Priority date | — |
| Expiry date | Jan 31, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharmaceutically acceptable carriers. The fibroblast growth factor may be a basic fibroblast growth factor or an analogue thereof, and the polysaccharide may be a carrageenan, heparin, dextran sulfate, pentosan polysulfate or a sulfated polysaccharides produced by marine algae belonging to the class of Rhodophyceae.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.